Invasive fungal infections in the pediatric intensive care unit: a clinical analysis of 38 cases

CAI Xiao-Fang; SUN Ji-Min; DONG Zong-Qi; LI Wen-Bin

doi:10.7499/j.issn.1008-8830.2013.08.010

PDF(712 KB)

Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (8) : 644-648. DOI: 10.7499/j.issn.1008-8830.2013.08.010

CLINICAL RESEARCH

Invasive fungal infections in the pediatric intensive care unit: a clinical analysis of 38 cases

CAI Xiao-Fang, SUN Ji-Min, DONG Zong-Qi, LI Wen-Bin

Author information +

History +

Abstract

OBJECTIVE: To investigate the clinical features of invasive fungal infections (IFI) in the pediatric intensive care unit (PICU) and, to provide a basis for the effective prevention and treatment of IFI. METHODS: Retrospective analysis was performed on the clinical features and treatment outcomes of 38 children with IFI who were admitted to the PICU of Wuhan Children’s Hospital between January 2009 and August 2012. RESULTS: Pulmonary fungal infection (89%) was the most common among the 38 cases. Before diagnosis of IFI, all patients had severe underlying diseases and received several broad-spectrum antibiotics, including carbapenems, which were used in 95% of cases; 47% of all cases had been treated with corticosteroids systemically; all patients had received invasive operations, and 47% of them had undergone endotracheal intubation and mechanical ventilation. None of these cases had either typical clinical symptoms and signs or specific imaging findings. Fifty-six strains of fungi were isolated, with Candida albicans (41%), Aspergilli (25%), and Mucor (20%) being the most common ones. All patients received timely antifungal therapies, 15 cases were cured and 16 cases showed improvements, with a response rate of 82%, and the rate of adverse events was 16%. CONCLUSIONS: In the PICU, the respiratory tract is the most common site of IFI infection, and Candida albicans is the leading pathogen. Severe underlying diseases, use of broad-spectrum antibiotics and corticosteroids, and invasive operations are the main risk factors for IFI in the PICU. Early diagnosis and timely treatment with high-performance antifungal drugs can improve the prognosis in children with IFI.

Key words

Intensive care unit / Invasive fungal infection / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CAI Xiao-Fang, SUN Ji-Min, DONG Zong-Qi, LI Wen-Bin. Invasive fungal infections in the pediatric intensive care unit: a clinical analysis of 38 cases[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(8): 644-648 https://doi.org/10.7499/j.issn.1008-8830.2013.08.010

References

[1] 李丁, 张鹏. 念珠菌性血流感染的流行病学研究进展[J]. 国际检验医学杂志, 2011, 1(1): 55-57.

[2] Conde-Rosa A, Amador R, Perez-Torres D, Colon E, Sanchez-Revera C, Nieves-Plaza M, et al. Candidemia distribution, associated risk factors, and attributed mortality at a university-based medical center[J]. PR Health Sci J, 2010, 29(1): 26-29.

[3] Christopher B, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review[J]. Pediatrics, 2007, 119(4): 772-784.

[4] 中华医学会重症医学分会. 重症患者侵袭性真菌感染诊断与治疗指南（2007） [J].中华内科杂志, 2007, 46(11): 960-966.

[5] 中华医学会儿科学分会呼吸学组, 中华儿科杂志编辑委员会. 儿童侵袭性肺部真菌感染诊治指南（2009版） [J]. 中华儿科杂志, 2009, 47(2): 96-98.

[6] 李萍, 张琦, 武焱旻, 汪敏, 李柯, 张建庭, 等. 伊曲康唑治疗侵袭性气道曲霉菌感染1例[J]. 中国实用内科杂志, 2010, 12(11) : 1152-1153.

[7] Qin J, Meng X, Fang Y, Xu C, Zhu K, Wu B, et al. Computed tomography and clinical features of invasive pulmonary aspergillosis in liver transplant recipients[J]. J Thorac Imaging, 2012, 27(2): 107-112.

[8] 黄敬孚. 侵袭性真菌感染及治疗策略[J]. 中国循证儿科杂志, 2007, 2(3): 212-219.

[9] Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis[J]. PLoS One, 2012, 7(8): e43347.

[10] Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis[J]. Lancet Infect Dis, 2009, 9(2): 89-96.

[11] Roilides E, Pana ZD. Application of diagnostic markers to invasive aspergillosis in children[J]. Ann N Y Acad Sci, 2012, 1272(1): 1-8.

[12] Dinleyici EC. Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes[J]. Expert Rev Anti Infect Ther, 2011, 9(3): 273-274.

[13] 常莉, 石华, 周伟, 胡正强, 母丽媛, 苏敏, 等. 儿童侵袭性真菌感染的临床特征及病原菌分析[J]. 中国当代儿科杂志, 2012, 14(12): 933-937.

[14] Cuqno C, Cesaro S. Epidemiology, risk factors and therapy of candidemia in pediatric hematological patients[J]. Pediatr Rep, 2012, 4(1): e9.

[15] Caston-Osorio JJ, Rivero A, Torte-Cisneros J. Epidemiology of invasive fungal infection[J]. Int J Antimicmb Agents, 2008, 32(Suppl 2): S103-S109.

[16] Moen MD, Lyseng-Williamson KA, Scott LJ. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections[J]. Drugs, 2009, 69(3): 361-392.

[17] 孙继民, 蔡小芳, 董宗祈, 张劲农. 伊曲康唑治疗儿童肺部真菌感染临床疗效及安全性评估[J]. 中国小儿急救医学, 2006, 13(6): 517-519.